Quantitative MRI analysis in children with multiple sclerosis: A multicenter feasibility pilot study

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Chitnis, Tanuja ^a   Guttmann, Charles R ^b   Zaitsev, Alexander ^b   Musallam, Alexander ^a   Weinstock Guttmann, Bianca ^c   Yeh, Ann ^c   Rodriguez, Moses ^d   Ness, Jayne ^f   Gorman, Mark P ^a   Healy, Brian C ^a   Kuntz, Nancy ^e   Chabas, Dorothee ^g   Strober, Jonathan B ^g   Waubant, Emmanuelle ^g   Krupp, Lauren ^h   Pelletier, Daniel ^g   Erickson, Bradley ^e   Bergsland, Niels ⁱ   Zivadinov, Robert ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

^d Department of Neurology and Immunology ^*  (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN DAMAGE; BRAIN SIZE; CAUCASIAN; CHILD; CONTRAST ENHANCEMENT; DEMOGRAPHY; DISEASE DURATION; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEASIBILITY STUDY; FEMALE; HISPANIC; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONSET AGE; PEDIATRIC HOSPITAL; PILOT STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; QUALITY CONTROL PROCEDURES; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RADIOLOGICAL PARAMETERS; SCHOOL CHILD; TREATMENT DURATION; UNITED STATES; CLINICAL TRIAL; DISABLED PERSON; PROCEDURES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISABLED PERSONS; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PILOT PROJECTS; UNITED STATES;

EID: 84887391002     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-173     Document Type: Article

References (23)

1. Duquette P, Murray TJ, Pleines J, Ebers GC, Sadovnick D, Weldon P, Warren S, Paty DW, Upton A, Hader W, et al. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987, 111(3):359-363. 10.1016/S0022-3476(87)80454-7, 3625402.
2. Ghezzi A, Deplano V, Faroni J, Grasso MG, Liguori M, Marrosu G, Pozzilli C, Simone IL, Zaffaroni M. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997, 3(1):43-46. 10.1177/135245859700300105, 9160345.
3. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009, 15(5):627-631. 10.1177/1352458508101933, 19299440.
4. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009, 66(1):54-59. 10.1001/archneurol.2008.505, 19139299.
5. Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, Moiola L, Falautano M, De Caro MF, Lopez M, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008, 70(20):1891-1897. 10.1212/01.wnl.0000312276.23177.fa, 18474844.
6. MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005, 64(8):1422-1425. 10.1212/01.WNL.0000158474.24191.BC, 15851734.
7. MacAllister WS, Christodoulou C, Milazzo M, Krupp LB. Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev Neuropsychol 2007, 32(2):625-644. 10.1080/87565640701375872, 17931122.
8. Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007, 356(25):2603-2613. 10.1056/NEJMoa067597, 17582070.
9. Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?. Neurology 2008, 71(14):1090-1093. 10.1212/01.wnl.0000326896.66714.ae, 18824673.
10. Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, Cox JL, Zivadinov R. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain 2009, 132(Pt 12):3392-3400.
11. Ghassemi R, Antel SB, Narayanan S, Francis SJ, Bar-Or A, Sadovnick AD, Banwell B, Arnold DL. Lesion distribution in children with clinically isolated syndromes. Ann Neurol 2008, 63(3):401-405. 10.1002/ana.21322, 18306242.
12. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68(16 Suppl 2):S7-12.
13. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001, 57(7):1239-1247. 10.1212/WNL.57.7.1239, 11591843.
14. Zivadinov R, Zorzon M, De Masi R, Nasuelli D, Cazzato G. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. J Neurol Sci 2008, 267(1-2):28-35.
15. Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG, Hussein S, Bergsland N, Munschauer FE, Zivadinov R. Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology 74(7):538-544.
16. Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler 2006, 12(6):775-781. 10.1177/1352458506070923, 17263006.
17. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races?. Neurology 2006, 66(8):1235-1240. 10.1212/01.wnl.0000208505.81912.82, 16636241.
18. Boster AL, Endress CF, Hreha SA, Caon C, Perumal JS, Khan OA. Pediatric-onset multiple sclerosis in African-American black and European-origin white patients. Pediatr Neurol 2009, 40(1):31-33. 10.1016/j.pediatrneurol.2008.09.004, 19068251.
19. Meier DS, Weiner HL, Guttmann CR. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability. AJNR Am J Neuroradiol 2007, 28(10):1956-1963. 10.3174/ajnr.A0701, 17998417.
20. Brunner J, Freund M, Prelog M, Binder E, Sailer-Hoeck M, Jungraithmayr T, Huemer C, Sergi C, Zimmerhackl LB. Successful treatment of severe juvenile microscopic polyangiitis with rituximab. Clin Rheumatol 2009, 28(8):997-999. 10.1007/s10067-009-1177-0, 19390907.
21. Zivadinov R, Stosic M, Cox JL, Ramasamy DP, Dwyer MG. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome. J Neurol 2008, 255(Suppl 1):61-74.
22. Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Moiola L, Falautano M, De Caro MF, Viterbo R, Patti F, et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology 2010, 75(13):1134-1140. 10.1212/WNL.0b013e3181f4d821, 20876467.
23. Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol 2013, 28(1):102-107. 10.1177/0883073812464816, 3652651, 23155206.